You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 13, April 6, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Women's Health, Other
 •Prognosis/ Outcomes
 •Hypertension
 •Alert me on articles by topic

Cardiovascular Outcomes and Antihypertensive Drug Treatment in Older Women

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The cohort study of cardiovascular outcomes and antihypertensive drug treatment by Dr Wassertheil-Smoller and colleagues1 used data from the Women’s Health Initiative Observational Study. We have a number of concerns that we believe limit drawing conclusions from this study. First, relative to the study sample size, the number of incident events was small and therefore the study may not have had adequate power to detect the end points in each subgroup (Tables 4 and 5 in the original article). For example, among women receiving a calcium channel blocker (CCB) plus an angiotensin-converting enzyme (ACE) inhibitor, only 8 cardiovascular deaths were reported. The P values for the overall comparison of therapies only reached borderline statistical significance for cardiovascular mortality, the outcome with the lowest annualized rates.

Second, the confidence intervals reported for the hazard ratios in Tables 5 and 7 in the original article have not been adjusted . . . [Full Text of this Article]

Jan A. Staessen, MD, PhD
jan.staessen@med.kuleuven.ac.be

Lutgarde Thijs, BSc
Department of Molecular and Cardiovascular Research
University of Leuven
Leuven, Belgium

Jiguang Wang, MD, PhD; Yan Li, MD, PhD
Centre for Clinical Trials and Epidemiology
Shanghai Institute of Hypertension
Shanghai, China


RELATED ARTICLES

Cardiovascular Outcomes and Antihypertensive Drug Treatment in Older Women
Michael Bursztyn
JAMA. 2005;293(13):1588.
EXTRACT | FULL TEXT  

Cardiovascular Outcomes and Antihypertensive Drug Treatment in Older Women—Reply
Sylvia Wassertheil-Smoller, Bruce Psaty, Philip Greenland, Albert Oberman, Theodore Kotchen, Charles Mouton, Henry Black, Aaron Aragaki, and Maurizio Trevisan
JAMA. 2005;293(13):1588-1589.
EXTRACT | FULL TEXT  

Association Between Cardiovascular Outcomes and Antihypertensive Drug Treatment in Older Women
Sylvia Wassertheil-Smoller, Bruce Psaty, Philip Greenland, Albert Oberman, Theodore Kotchen, Charles Mouton, Henry Black, Aaron Aragaki, and Maurizio Trevisan
JAMA. 2004;292(23):2849-2859.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.